Wave Life Sciences

WVENasdaq Singapore Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.202 B

$6.10 +1.33%

Close of 7 Aug 2026

Revenue

$42.7M

#2792 by revenue

Earnings

-$204.4M

Loss-making

Shares outstanding

197,048,175

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#149Seaport TherapeuticsSPTX$1.26B
#150Eton PharmaceuticalsETON$1.22B
#151Wave Life SciencesWVE$1.20B
#152SavaraSVRA$1.19B
#153Corvus PharmaceuticalsCRVS$1.17B

Where these numbers come from

Share counts and financials for Wave Life Sciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.